Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-07-19
2011-07-19
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S042000, C544S044000
Reexamination Certificate
active
07981885
ABSTRACT:
The present invention relates to inhibiting proliferation and inducing apoptosis in activated lymphocytes, including T cells and B cells. The invention also provides compositions and methods for inhibiting proliferation and inducing apoptosis in activated lymphocytes, as well methods for treating diseases associated with activated lymphocytes by administering 5-HT receptor antagonists.
REFERENCES:
patent: 2645640 (1953-07-01), Charpentier
patent: 2687414 (1954-08-01), Cusic
patent: 2957870 (1960-10-01), Cusic
patent: 3058979 (1962-10-01), Ullyot
patent: 3194733 (1965-07-01), Yale
patent: 5595989 (1997-01-01), Andersen et al.
patent: 6333322 (2001-12-01), Miyamoto et al.
patent: 6815450 (2004-11-01), He et al.
patent: 2003/0032801 (2003-02-01), Lin et al.
patent: 2005/0080075 (2005-04-01), Nichols et al.
patent: 0889037 (1999-01-01), None
patent: 2218102 (1974-09-01), None
patent: 857547 (1956-12-01), None
patent: 824598 (1959-12-01), None
patent: 903725 (1962-08-01), None
patent: WO 02/089810 (2002-11-01), None
patent: WO 03/062388 (2003-07-01), None
patent: WO 03/106660 (2003-12-01), None
Richard Dahlbom Acta Chemica Scandinavica (1949), 3, 247-55.
Nieschuz et al. Arzneimittel-Forschung (1957), 7, 106-13.
Aune et al., 1990, J. Immunol. 145:1826-1831.
Aune et al., 1993, J. Immunol. 151:1175-1183.
Aune et al., 1994, J. Immunol. 153:1826-1831.
Foon et al., 1976, J. Immunol. 117:1545-1552.
Khan et al., 1986, Int. Arch. Allergy Appl. Immunol. 81:378-380.
Kut et al., 1992, Immunopharmacol. Immunotoxicol. 14:783-796.
Mossner & Lesch, 1998, Brain, Behavior, and Immunity 12:249-271.
Slauson et al., 1984, Cell. Immunol. 84:240-252.
Young et al., 1993, Immunology 80:395-400.
Hromatka, et al., “Untersuchungen über Phenthiazinderivate, 20. Mitt.: Carbonsäuren von basisch substituierten Phenthiazinderivaten und deren Ester,” Jan. 1962, vol. 93, No. 6, pp. 1288-1293, XP009137937.
Buck Clayton
Olson Gary
Roth Stephen
Self Christopher
Habte Kahsay T
Immune Control Inc.
Riverside Law LLP
LandOfFree
Compositions for treatment of diseases related to activated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for treatment of diseases related to activated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for treatment of diseases related to activated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2687574